The use of antibiotics commonly associated with antimicrobial resistance: a UK network cohort study using primary and hospital care data

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objectives

To describe and compare patterns of use and potential indications of antibiotics in the WHO AWaRe classification Watch list in UK NHS community care and hospital care settings.

Design

Retrospective observational cohort study using routinely collected electronic health record data.

Setting

Community and hospital care in England and Scotland.

Participants

We included 12,139,211 records covering 33 different Watch antibiotics used in UK hospitals and community care settings.

Main outcome measures

Outcomes were incident prescription / dispensation records of each WHO AWaRe classification Watch list antibiotic between 2022 to last date of data capture for hospital care and from 2012 for community care. Conditions of interest captured 14 days before and after Watch list antibiotic use. Previous use of Access and other Watch list antibiotics were captured 14 days up to 1 day before each Watch list antibiotic.

Results

Our study found marked differences between community and hospital care in the use of Watch antibiotics. In community care, incidence trends for commonly used Watch antibiotics typically declined or remained stable between 2012 and 2024 (e.g., fusidate: from 2,471 to 438 per 100,000 person-years in CPRD Aurum; from 3,594 to 1,561 in DataLoch), with clear seasonality in their use and higher incidence between October and March. Watch antibiotic use in community care was typically linked to mild, common infections such as skin or respiratory tract infections. In hospital care, Watch antibiotic use was more often associated with clinically severe infections such as sepsis (e.g., vancomycin: from 12.2% of users in Leeds to 28.0% in Lancashire) and exacerbations of COPD (e.g., azithromycin: from 1.4% in GOSH to 65.7% in Lancashire). Prior use of Access and other Watch antibiotics was recorded in both community and hospital care, though this was generally observed in fewer than half of patients.

Conclusions

Overall, our findings suggest that Watch antibiotic use reflects the contrasting clinical contexts of community and hospital care, with milder infections predominating in the community and more severe infections in hospitals. However, regional and demographic variation indicates areas where prescribing practices could be refined. Ongoing surveillance and targeted stewardship interventions are essential to promote appropriate use and prevent resistance.

Summary boxes

Section 1: What is already known on this topic

  • Antibiotic prescribing / dispensing patterns can vary across care settings with most studies focusing on either community or hospital care in isolation.

  • The WHO AWaRe classification highlights the need to monitor the use of Watch due to their higher potential to drive antimicrobial resistance.

  • There is limited evidence across UK healthcare datasets examining real-world use of Watch list antibiotics and associated clinical indications.

Section 2: What this study adds

  • Variations in Watch list antibiotic prescribing / dispensing occur across community and hospital care settings.

  • Conditions of interest of Watch list antibiotics patients were relatively consistent across general hospitals apart from paediatric hospital care and community care.

Article activity feed